论文部分内容阅读
目的:研究妈富隆用于改善放置宫内节育器初期子宫异常出血的临床效果。方法:将在2013年12月至2015年11月间选取在我院放置节育器的230名已生育并符合计划生育要求的产妇为研究对象,将对象分组后进行不同方法的预防治疗,并对评价指标内容进行对比研究。结果:采用妈富隆的观察组第一次和第二次月经时间均优于未采用任何药物的对照组,P<0.05;观察组的点滴出血时间在第二次月经期内优于对照组,P<0.05。均有统计学意义。两组的点滴出血时间在第一次月经前基本接近,P>0.05,无统计学意义。结论:对放置宫内节育器的女性采用妈富隆可以有效改善初期子宫异常出血的情况,也对女性生殖系统的健康起到较好的保障作用,值得临床推广应用。
Objective: To study the clinical effect of Marvelon on improving the abnormal uterine bleeding in early stage of IUD insertion. Methods: Between December 2013 and November 2015, 230 pregnant women who had birth control and family planning requirements were enrolled in our hospital from January 2013 to November 2015. Subjects were divided into groups and then treated with different methods. Evaluation of the contents of the content of a comparative study. Results: The first and second menstrual time in the observation group with Marvelon were all better than those in the control group without any drug, P <0.05; the bleeding time in the observation group was better than that in the control group in the second menstrual period, P <0.05. All have statistical significance. Bleeding time of the two groups before the first menstruation basically close, P> 0.05, no statistical significance. Conclusion: The use of Marvelon for women with IUD placement can effectively improve the abnormal uterine bleeding in the early stage, and also protect the health of the female reproductive system. It is worthy of clinical application.